High-throughput assays to assess variant effects on disease

K Ma, LO Gauthier, F Cheung… - Disease Models & …, 2024 - journals.biologists.com
Interpreting the wealth of rare genetic variants discovered in population-scale sequencing
efforts and deciphering their associations with human health and disease present a critical …

ESCRT-mediated uptake and degradation of brain-targeted α-synuclein single chain antibody attenuates neuronal degeneration in vivo

B Spencer, S Emadi, P Desplats, S Eleuteri, S Michael… - Molecular Therapy, 2014 - cell.com
Parkinson's disease and dementia with Lewy bodies are neurodegenerative disorders
characterized by accumulation of α-synuclein (α-syn). Recently, single-chain fragment …

[HTML][HTML] Glucarpidase (carboxypeptidase G2): Biotechnological production, clinical application as a methotrexate antidote, and placement in targeted cancer therapy

F Moradbeygi, Y Ghasemi, AR Farmani… - Biomedicine & …, 2023 - Elsevier
Patients receiving high-dose methotrexate (HDMTX) for malignancies are exposed to
diverse complications, including nephrotoxicity, hepatotoxicity, mucositis, myelotoxicity …

Adding functions to biomaterial surfaces through protein incorporation

MA Wronska, IB O'Connor, MA Tilbury… - Advanced …, 2016 - Wiley Online Library
The concept of biomaterials has evolved from one of inert mechanical supports with a long‐
term, biologically inactive role in the body into complex matrices that exhibit selective cell …

Targeting of IL-10R on acute myeloid leukemia blasts with chimeric antigen receptor-expressing T cells

N Chen, Y Xu, J Mou, Q Rao, H Xing, Z Tian… - Blood Cancer …, 2021 - nature.com
Acute myeloid leukemia (AML) is a biologically and clinically heterogeneous disease with a
dismal prognosis and limited treatment options. Chimeric antigen receptor (CAR) T cells …

Combining of oncolytic virotherapy and other immunotherapeutic approaches in cancer: a powerful functionalization tactic

H Zou, XZ Mou, B Zhu - Global Challenges, 2023 - Wiley Online Library
Oncolytic viruses have found a good place in the treatment of cancer. Administering
oncolytic viruses directly or by applying genetic changes can be effective in cancer treatment …

[HTML][HTML] Application of recombinant antibodies for treatment of Clostridioides difficile infection: Current status and future perspective

H Raeisi, M Azimirad, A Nabavi-Rad… - Frontiers in …, 2022 - frontiersin.org
Clostridioides difficile (C. difficile), known as the major cause of antibiotic-associated
diarrhea, is regarded as one of the most common healthcare-associated bacterial infections …

The use of nanoparticles as a promising therapeutic approach in cancer immunotherapy

M Hosseini, M Haji-Fatahaliha… - Artificial cells …, 2016 - Taylor & Francis
Cancer is one of the most important causes of death all over the world, which has not yet
been treated efficiently. Although several therapeutic approaches have been used, some …

AAV‐mediated delivery of an anti‐BACE1 VHH alleviates pathology in an Alzheimer's disease model

M Marino, L Zhou, MY Rincon… - EMBO molecular …, 2022 - embopress.org
Single domain antibodies (VHHs) are potentially disruptive therapeutics, with important
biological value for treatment of several diseases, including neurological disorders …

Antibody-receptor bioengineering and its implications in designing bioelectronic devices

DS Dkhar, R Kumari, S Mahapatra, R Kumar… - International Journal of …, 2022 - Elsevier
Antibodies play a crucial role in the defense mechanism countering pathogens or foreign
antigens in eukaryotes. Its potential as an analytical and diagnostic tool has been exploited …